1. bookVolumen 63 (2013): Edición 3 (September 2013)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Synthesis, in vitro anticancer and antioxidant activity of thiadiazole substituted thiazolidin-4-ones

Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. R. L. Prior, X. Wu and K. Schaichs, Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements, J. Agric. Food Chem. 53 (2005) 4290-4302.10.1021/jf0502698Search in Google Scholar

2. A. O. H. El-Nezhawy, M. M. Ramla, N. M. Khalifa and M. M. Abdulla, Synthesis and antioxidant activity of some thiazolidin-4-one derivatives, Monatsh. Chem. 140 (2009) 531-539; DOI: 10. 1007/s00706-008-0085-3.10.1007/s00706-008-0085-3Search in Google Scholar

3. S. Grasso, A. Chimirri, P. Monforte and G. Fenech, Compounds with presumed antitumor activity. II. 2-Substituted 3-(2-thiazolyl)- and 3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones, Farmaco 39 (1984) 505-513.Search in Google Scholar

4. S. Grasso, A. Chimirri, P. Monforte, G. Fenech, M. Zappala and A. M. Monforte, Compounds with potential antitumor activity. VI. 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones, Farmaco43 (1988) 851-856.Search in Google Scholar

5. A. A. Geronikaki, A. A. Lagunin, D. I. Hadjipavlou-Litina, P. T. Eleftheriou, D. A. Filimonov, V. V. Poroikov, I. Alam, and A. K. Saxena, Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition, J. Med. Chem. 51 (2008) 1601-1609; DOI: 10.1021/jm701496h.10.1021/jm701496hSearch in Google Scholar

6. S. K. Bhati and A. Kumar, Synthesis of new substituted azetidinoyl and thiazolidinoyl-1,3,4- thiadiazino (6,5-b) indoles as promising anti-inflammatory agents, Eur. J. Med. Chem. 43 (2008) 2323-2330; DOI: 10.1016/j.ejmech.2007.10.012.10.1016/j.ejmech.2007.10.012Search in Google Scholar

7. V. Dwivedi and R. K. Aggarwal, Synthesis and fungicidal activities of some 2-furyl-3-[(5-aryloxymethyl)-1,3,4-thiadiazol-2-yl]thiazolidin-4-ones, Asian J. Chem. 4 (1992) 780-784.Search in Google Scholar

8. V. B. Gaur, V. H. Shah and A. R. Parikh, Studies on 4-thiazolidinones. Preparation and antimicrobial activity of 2-aryl-3-(5-o-hydroxyphenyl/p-nitrophenyl-1,3,4-thiadiazol-2-yl)-5-carboxymethyl-4-thiazolidinones, Acta Cienc. Indica Chem. 16C (1990) 437-444.Search in Google Scholar

9. R. K. Rawal, R. Tripathi, S. B. Katti, C. Pannecouque and E. D. Clercq, Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents, Bioorg. Med. Chem.15 (2007) 1725-1731; DOI: 10.1016/j.bmc.2006.12.003.10.1016/j.bmc.2006.12.003Search in Google Scholar

10. R. K. Rawal, R. Tripathi, S. B. Katti, C. Pannecouque and E. D. Clercq, Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents, Eur. J. Med. Chem. 43 (2008) 2800-2806; DOI: 10.1016/j.ejmech.2007.12.015.10.1016/j.ejmech.2007.12.015Search in Google Scholar

11. R. K. Rawal, S. B. Katti, N. Kaushik-Basu, P. Arora and Z. Pan, Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependent RNA polymerase: 2-Aryl-3-heteroaryl-1,3-thiazolidin- -4-one derivatives, Bioorg. Med. Chem. Lett. 18 (2008) 6110-6114; DOI: 10.1016/j.bmcl.2008.10.02310.1016/j.bmcl.2008.10.023Search in Google Scholar

12. A. Chimirri, S. Grasso, A. M. Monforte, M. Zappala, A. De Sarro and G. B. De Sarro, Synthesis and anticonvulsant properties of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-ones, Farmaco 46 (1991) 935-943.Search in Google Scholar

13. Archana, V. K. Srivastava and A. Kumar, Synthesis of newer thiadiazolyl and thiazolidinonyl quinazolin-4(3H)-ones as potential anticonvulsant agents, Eur. J. Med. Chem. 37 (2002) 873-882; DOI: 10.1016/S0223-5234(02)01389-2.10.1016/S0223-5234(02)01389-2Search in Google Scholar

14. S. V. Bhandari, K. G. Bothara, A. A. Patil, T. S. Chitre, A. P. Sarkate, S. T. Gore, S. C. Dangre and C. V. Khachane, Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach, Bioorg. Med. Chem. 17 (2009) 390-400; DOI: 10.1016/j.bmc.2008. 10.032.Search in Google Scholar

15. A. Geronikaki, P. Eleftheriou, P. Vicini, I. Alam, A. Dixit and A. K. Saxena, 2-Thiazolylimino/ heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action, J. Med. Chem. 51 (2008) 5221-5228; DOI: 10.1021/jm8004306.10.1021/jm800430618702480Search in Google Scholar

16. N. S. Cutshall, C. O’Day and M. Prezhdo, Rhodanine derivatives as inhibitors of JSP-1, Bioorg. Med. Chem. Lett. 15 (2005) 3374-3379.10.1016/j.bmcl.2005.05.03415961311Search in Google Scholar

17. P. H. Carter, P. A. Scherle, J. A. Muckelbauer, M. E. Voss, R. Q. Liu, L. A. Thompson, A. J. Tebben, K. A. Solomon, Y. C. Lo, Z. Li, P. Strzemienski, G. Yang, N. Falahatpisheh, M. Xu, Z. Wu, N.A. Farrow, K. Ramnarayan, J. Wang, D. Rideout, V. Yalamoori, P. Domaille, D. J. Underwood, J. M. Trzaskos, S. M. Friedman, R. C. Newton and C. P. Decicco, Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha, Proc. Natl. Acad. Sci. USA 98 (2001) 11879-11884.10.1073/pnas.211178398Search in Google Scholar

18. A. Degterev, A. Lugovskoy, M. Cardone, B. Mulley, G. Wagner, T. Mitchison and J. Yuan, Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xl, Nat. Cell Biol. 3 (2001) 173-182.10.1038/35055085Search in Google Scholar

19. R. Dayam, F. Aiello, J. Deng, Y. Wu, A. Garofalo, X. Chen and N. Neamati, Discovery of small molecule integrin avb3 antagonists as novel anticancer agents, J. Med. Chem. 49 (2006) 4526-4534; DOI: 10.1021/jm051296s.10.1021/jm051296sSearch in Google Scholar

20. A. Senff-Ribeiro, A. Echevarria, E. F. Silva, S. S. Veiga and M. B. Oliveira, Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study, Anticancer Drugs15 (2004) 269-275.Search in Google Scholar

21. R. F. Asbury, J. A. Blessing and D. Moore, A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a gynecologic oncology group study, Am. J. Clin. Oncol. 19 (1996) 400-402.Search in Google Scholar

22. J. Y. Chou, S. Y. Lai, S. L. Pan, G. M. Jow, J. W. Chern and J. H. Guh, Investigation of anticancer mechanism of thiadiazole-based compound in human non-small cell lung cancer A549 cells, Biochem. Pharmacol. 66 (2003) 115-124; DOI: 10.1016/S0006-2952(03)00254-5.10.1016/S0006-2952(03)00254-5Search in Google Scholar

23. S. K. Suthar, V. Jaiswal, S. Lohan, S. Bansal, A. Chaudhary, A. Tiwari, A. T. Alex and A. Joseph, Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: Design, synthesis and biological screening, Eur. J. Med Chem. 63 (2013) 589-602; DOI: 10.1016/j. ejmech.2013.03.011.Search in Google Scholar

24. P. Mishra, V. Jatav and S. K. Kashaw, Some novel 2-methyl-3-(1’3’4’-thiazolyl)-4-(3H)quinazolinones with anticonvulsant and CNS depressant activity, J. Indian Chem. Soc. 83 (2006) 1165-1170.Search in Google Scholar

25. C. V. Kavitha, Basappa, S. N. Swamy, K. Mantelingu, S. Doreswamy, M. A. Sridhar, J. S. Prasad and K. K. S. Rangappa, Synthesis of new bioactive venlafaxine analogs: Novel thiazolidin-4- ones as antimicrobials, Bioorg. Med. Chem. 14 (2006) 2290-2299; DOI: 10.1016/j.bmc.2005.11.017.10.1016/j.bmc.2005.11.01716338140Search in Google Scholar

26. L. L. Mensor, F. S. Menzes, G. G. Leitao, A. S. Reis, T. C. Dosantos, C. S. Coube and S. G. Leitao, Screening of Brazilian extract for antioxidant activity by the DPPH free radical method, Phytother. Res. 15 (2001) 127-130; DOI: 10.1002/ptr.687.10.1002/ptr.68711268111Search in Google Scholar

27. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63; DOI: 10.1016/0022-1759(83) 90303-4. Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo